Roche Holding | ROG - Pre Tax Profit

Stock Price
315.60
Daily Change
-1.10 -0.35%
Monthly
-4.36%
Yearly
29.45%
Q2 Forecast
309.99

Roche Holding reported CHF4.79B in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Alcon AG USD 264M 19M Dec/2025
Almirall EUR 30.32M 22M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Fresenius EUR 601M 122M Dec/2025
Fresenius Medical Care EUR 508.46M 105.89M Dec/2025
Galapagos EUR -221.49M 117.07M Sep/2025
Genmab DKK 55M 427M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 1.29B 458.1M Sep/2025
Merck USD 6.74B 22M Sep/2025
Novartis USD 4.64B 445M Dec/2025
Orion EUR 327M 206.6M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
Philips EUR 275M 62M Sep/2025
Recordati EUR 144.95M 25.46M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025